ReviewBiotechnologia2026
Trends in developing nanoparticle-enhanced electrochemical sensors for neurotransmitter detection: a review.
Review in Biotechnologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nano-biosensors represent innovative analytical devices that couple nanotechnology with biomolecular recognition elements to detect specific targets with high sensitivity and selectivity. By incorporating nanomaterials such as gold, carbon, or metal oxides, these devices exhibit enhanced conductivity, larger surface areas, and improved electron transfer, thereby enabling rapid and accurate detection even at ultralow concentrations. Electrochemical nano-biosensors are particularly advantageous for medical diagnostics, health monitoring, and environmental applications because they convert bioreceptor-analyte interactions into measurable real-time electrical signals. Due to their ability to monitor key biomarkers, including neurotransmitters, these sensors hold immense promise for early disease diagnosis, therapeutic monitoring, and neurological research. This review highlights current trends in the development of nanomaterial-enhanced electrochemical sensors for neurotransmitter detection, focuses on their performance and clinical translation potential, and outlines future directions to address challenges in selectivity, stability, and large-scale manufacturing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.